PubRank

S J Freedland

Author PubWeight™ 22.50‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Obstructive uropathy secondary to ureteroinguinal herniation. Rev Urol 2001 1.33
2 Metformin does not affect risk of biochemical recurrence following radical prostatectomy: results from the SEARCH database. Prostate Cancer Prostatic Dis 2013 1.20
3 Race is associated with discontinuation of active surveillance of low-risk prostate cancer: results from the Duke Prostate Center. Prostate Cancer Prostatic Dis 2012 1.10
4 Race and prostate weight as independent predictors for biochemical recurrence after radical prostatectomy. Prostate Cancer Prostatic Dis 2008 1.07
5 Prostate biopsies from black men express higher levels of aggressive disease biomarkers than prostate biopsies from white men. Prostate Cancer Prostatic Dis 2011 1.03
6 Effect of intermittent fasting on prostate cancer tumor growth in a mouse model. Prostate Cancer Prostatic Dis 2010 1.01
7 The influence of hepatic function on prostate cancer outcomes after radical prostatectomy. Prostate Cancer Prostatic Dis 2010 1.00
8 Diabetes and prostate cancer risk in the REDUCE trial. Prostate Cancer Prostatic Dis 2011 0.97
9 The effect of race on the discriminatory accuracy of models to predict biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases. Prostate Cancer Prostatic Dis 2009 0.95
10 Predictive value of digital rectal examination for prostate cancer detection is modified by obesity. Prostate Cancer Prostatic Dis 2011 0.93
11 Preoperative weight change and risk of adverse outcome following radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital database. Prostate Cancer Prostatic Dis 2011 0.92
12 Impact of nerve sparing on surgical margins and biochemical recurrence: results from the SEARCH database. Prostate Cancer Prostatic Dis 2008 0.87
13 Prostate cancer risk in men with prostate and breast cancer family history: results from the REDUCE study (R1). J Intern Med 2012 0.87
14 Exercise therapy across the prostate cancer continuum. Prostate Cancer Prostatic Dis 2009 0.84
15 The uncertain relationship between obesity and prostate cancer: an Italian biopsy cohort analysis. Eur J Surg Oncol 2011 0.83
16 Polyarteritis nodosa presenting as hematuria and a testicular mass. J Urol 2001 0.83
17 Bladder cancer 2000: molecular markers for the diagnosis of transitional cell carcinoma. Rev Urol 2001 0.82
18 Fish oil slows prostate cancer xenograft growth relative to other dietary fats and is associated with decreased mitochondrial and insulin pathway gene expression. Prostate Cancer Prostatic Dis 2013 0.82
19 Preoperative predictors of blood loss at the time of radical prostatectomy: results from the SEARCH database. Prostate Cancer Prostatic Dis 2009 0.82
20 Can we lower the mortality rate of black men with prostate cancer? J Urol 2000 0.80
21 Factors altering ribozyme-mediated cleavage of tumor necrosis factor-alpha mRNA in vitro. Biochem Biophys Res Commun 1997 0.76
22 Biomarkers for early detection and optimized treatment for transitional cell carcinoma. Rev Urol 2001 0.75
23 Rethinking staging and treatment for renal cell cancer. Rev Urol 2001 0.75
24 Conservative management of a grade 4 renal laceration in a child. Rev Urol 2001 0.75
25 Determining the optimal treatment for advanced bladder cancer. Rev Urol 2001 0.75
26 Urology in the desert 2000: highlights from the 76th annual meeting of the Western section american urological association. Rev Urol 2001 0.75
27 Editor's comments. Prostate Cancer Prostatic Dis 2011 0.75
28 Prostate Cancer and Prostatic Diseases (2012) 15, 313. Prostate Cancer Prostatic Dis 2012 0.75
29 Towards kidney cancer crystal ball. Better prognostication of patients with renal cell carcinoma. J Urol 2001 0.75
30 Prostate Cancer and Prostatic Diseases. Editor's comments. Prostate Cancer Prostatic Dis 2010 0.75